Hatch/Waxman Act Allows Potential Copyright Infringement - Court
This article was originally published in The Tan Sheet
Executive Summary
A New York City federal appeals court unanimously ruled in favor of Watson Pharmaceuticals April 4, lifting a preliminary injunction against the sale of its generic OTC nicotine polacrilex gum and dismissing SmithKline Beecham Consumer Healthcare's copyright infringement action.